Last €8.31 EUR
Change Today -0.02 / -0.24%
Volume 22.1K
ALDEI On Other Exchanges
EN Paris
As of 9:29 AM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

deinove (ALDEI) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/7/14 - €16.20
52 Week Low
01/29/15 - €5.90
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DEINOVE (ALDEI)

Related News

No related news articles were found.

deinove (ALDEI) Related Businessweek News

No Related Businessweek News Found

deinove (ALDEI) Details

Deinove SA, a cleantech company, designs, develops, and markets industrial processes based on the Deinococcus bacteria. It is involved in the development and commercial exploitation of processes for the production of biofuels and other products of industrial or pharmaceutical interest. The company was founded in 2006 and is headquartered in Paris, France.

43 Employees
Last Reported Date: 09/20/14
Founded in 2006

deinove (ALDEI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

deinove (ALDEI) Key Developments

Deinove SA Presents at Pacific Rim Summit 2014, Dec-09-2014 04:00 PM

Deinove SA Presents at Pacific Rim Summit 2014, Dec-09-2014 04:00 PM. Venue: San Diego, California, United States. Speakers: Nagib Ward, Vice President of Business Development.

Deinove SA and Sofiproteol Signs Collaboration Agreement to Develop Production Process for Natural Feed Additives

DEINOVE SA and SOFIPROTÉOL reports signing a three-year collaboration agreement to develop a production process for natural feed additives. This project, named COLOR2B, is part of the DEINOCHEM program and primarily targets the animal feed market, although it also opens up opportunities in human food applications. COLOR2B is an R&D project, which aims at developing a production process for natural feed additives. This includes selecting the best-performing bacteria strains from DEINOVE's strain bank, testing the compounds produced, qualifying their benefits for animal nutrition and health as well as developing the production process at pilot-scale. DEINOVE's expertise will focus on producing additives from their bacterial micro-factories, in an eco-friendly and economically viable way. SOFIPROTEOL's expertise will apply to feedstock selection, evaluation of the beneficial effects for animals, knowledge of the market and associated regulations, as well as marketing the technology developed.

Deinove Announces Earnings Results for First Half Ended June 30, 2014

Deinove announced earnings results for first half ended June 30, 2014. The net result for the first half of 2014 is a loss of EUR 3.920 million compared to a loss of EUR 1.291 million for the same period in the previous year. This result reflects the company's change in size which, in one year, went from the status of young company established in a business incubator to that of a company preparing the industrialization of its processes, whose team has grown and become structured and which now has its own laboratories. The net result is also impacted by non-recurring costs related to the capital increase project canceled at the start of July. Total operating income was EUR 16,000 compared to EUR 5,000 reported a year ago. Operating loss was EUR 3.772 million compared to a loss of EUR 2.622 million reported a year ago. Pre-tax loss was EUR 3.743 million compared to a loss of EUR 2.567 million reported a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALDEI:FP €8.31 EUR -0.02

ALDEI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALDEI.
View Industry Companies

Industry Analysis


Industry Average

Valuation ALDEI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 573.2x
Price/Book 6.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 567.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEINOVE, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at